Shareholders Equity: The sum of preferred and common equity items.
AC Immune (ACIU) had Shareholders Equity of $165.38M for the most recently reported fiscal quarter, ending 2024-03-31.
| Income Statement Financials | |
-- |
|
$-20.42M |
|
-- |
|
-- |
|
$22.94M |
|
$-22.94M |
|
$2.52M |
|
$-20.42M |
|
$-20.42M |
|
$-20.42M |
|
$-20.42M |
|
$-20.42M |
|
$-20.42M |
|
$-22.94M |
|
$-22.30M |
|
99.39M |
|
99.39M |
|
$-0.21 |
|
$-0.21 |
|
| Balance Sheet Financials | |
$125.60M |
|
$3.70M |
|
$65.62M |
|
$191.22M |
|
$16.15M |
|
-- |
|
$9.69M |
|
$25.83M |
|
$165.38M |
|
$107.75M |
|
|
Shareholders Equity |
$165.38M |
-- |
|
| Cash Flow Statement Financials | |
$1.17M |
|
$-26.93M |
|
$-0.79M |
|
$89.73M |
|
$65.17M |
|
$-24.56M |
|
$2.15M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
7.78 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$0.89M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-12.35% |
|
-18.95% |
|
-10.68% |
|
-12.35% |
|
-- |
|
$0.01 |
|
$0.01 |
|